Technology

Combining Astrazeneca with Pfizer is “safe and effective”, according to the Carlos III Institute

Updated: Tuesday, May 18, 2021 12:11 PM

Published on: 05/18/2021 12:10

Jesús Antonio Frías, coordinator of the clinical research network of the Carlos III Health Institute, explained in the presentation of the study that “we, as researchers, can only conclude that the administration of a dose of booster through a heterologous vaccination schedule is highly immunogenic. antibodies between 30 and 40 times from seven to fourteen days, and the adverse effects are similar to those that other programs have had in single administration schedules, in no case serious or have they led to hospitalizations. ”

We expand information

semidedicated hosting
Back to top button